You can:
Name | Neuropeptide Y receptor type 2 |
---|---|
Species | Cavia porcellus (Guinea pig) |
Gene | NPY2R |
Synonym | NPY-Y2 receptor NPY2-R Y2 receptor |
Disease | N/A for non-human GPCRs |
Length | 381 |
Amino acid sequence | MGPIGTEADENQTVEEIKVEPYGPGHTTPRGELAPDPEPELIDSTKLTEVRVVLILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTVTLTVIALDRHRCIVYHLDSKISKQNSFLIIGLAWGISALLASPLAIFREYSLIEIIPDFEIVACTEKWPGEEKSIYGTVYSLSSLLILYVLPLGIISVSYVRIWSKLKNHVSPGAANDHYHQRRQKTTKMLVFVVVVFAVSWLPLHAFQLAVDIDSQVLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRCQQRLDAIQSEVCVTGKAKTNVEVEKNHGAADSAEATNV |
UniProt | Q9Z2D5 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | N/A |
IUPHAR | N/A |
DrugBank | N/A |
Name | NPY8-20, Pro34, Ahx |
---|---|
Molecular formula | C135H207N39O35 |
IUPAC name | (3S)-4-[[(2S)-4-amino-1-[[6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-1,4-dioxobutan-2-yl]amino]-3-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid |
Molecular weight | 2936.38 |
Hydrogen bond acceptor | 41 |
Hydrogen bond donor | 43 |
XlogP | -7.7 |
Synonyms | BDBM85374 |
Inchi Key | MGPBDEBSKDNSSJ-UMNSLXQDSA-N |
Inchi ID | InChI=1S/C135H207N39O35/c1-11-72(8)108(128(205)166-96(63-104(139)183)118(195)161-91(56-70(4)5)120(197)169-107(71(6)7)127(204)171-109(74(10)177)129(206)158-88(26-19-51-151-135(145)146)132(209)173-53-21-28-101(173)124(201)156-86(25-18-50-150-134(143)144)113(190)159-89(110(140)187)58-76-33-41-81(179)42-34-76)170-121(198)93(60-78-37-45-83(181)46-38-78)162-117(194)94(61-79-65-147-68-152-79)163-114(191)85(24-17-49-149-133(141)142)155-115(192)90(55-69(2)3)160-111(188)73(9)153-122(199)98(66-175)167-116(193)92(59-77-35-43-82(180)44-36-77)154-105(184)30-13-12-16-48-148-112(189)95(62-103(138)182)164-119(196)97(64-106(185)186)165-125(202)102-29-22-54-174(102)131(208)87(23-14-15-47-136)157-123(200)99(67-176)168-126(203)100-27-20-52-172(100)130(207)84(137)57-75-31-39-80(178)40-32-75/h31-46,65,68-74,84-102,107-109,175-181H,11-30,47-64,66-67,136-137H2,1-10H3,(H2,138,182)(H2,139,183)(H2,140,187)(H,147,152)(H,148,189)(H,153,199)(H,154,184)(H,155,192)(H,156,201)(H,157,200)(H,158,206)(H,159,190)(H,160,188)(H,161,195)(H,162,194)(H,163,191)(H,164,196)(H,165,202)(H,166,205)(H,167,193)(H,168,203)(H,169,197)(H,170,198)(H,171,204)(H,185,186)(H4,141,142,149)(H4,143,144,150)(H4,145,146,151)/t72-,73-,74+,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,107-,108-,109-/m0/s1 |
PubChem CID | 91898958 |
ChEMBL | N/A |
IUPHAR | N/A |
BindingDB | 85374 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 85.3 nM | PMID9802390 | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417